ArticleNeuro-oncology2023

Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.

Michael C Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.